Shares of Sernova Corp. (TSE:SVA – Get Free Report) were down 4.5% on Friday . The company traded as low as C$0.21 and last traded at C$0.21. Approximately 56,087 shares changed hands during trading, a decline of 64% from the average daily volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Price Performance
The company has a debt-to-equity ratio of 16.55, a quick ratio of 18.11 and a current ratio of 0.32. The firm has a market capitalization of C$68.32 million, a price-to-earnings ratio of -1.62 and a beta of 1.35. The business has a fifty day moving average of C$0.23 and a two-hundred day moving average of C$0.25.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
- Five stocks we like better than Sernova
- What Does Downgrade Mean in Investing?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is MarketRank™? How to Use it
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
